Detection of intrahepatic hepatitis B virus DNA and correlation with hepatic necroinflammation and fibrosis.
Ontology highlight
ABSTRACT: Assessment of intrahepatic hepatitis B virus (HBV) DNA levels in patients with chronic hepatitis B is important in understanding the natural history of the disease and designing antiviral therapy regimens. However, there is no standardized method for the measurement of intrahepatic HBV DNA levels. We describe a convenient novel method for the measurement of intrahepatic HBV DNA levels based on a modified COBAS Amplicor HBV Monitor test for HBV DNA measurement and real-time PCR beta-actin gene detection for human genomic DNA (hgDNA) quantitation. Fifteen hepatitis B e antigen (HBeAg)-positive patients, 26 patients positive for antibody to HBeAg (anti-HBe), and 8 control patients were recruited. The mean between-run coefficient of variation for the beta-actin real-time PCR assay was 15.4%. A
SUBMITTER: Wong DK
PROVIDER: S-EPMC516337 | biostudies-literature | 2004 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA